Ozempic And Wegovy Rivals: Here Are The Companies Working On Competitor Weight Loss Drugs

  • 📰 Forbes
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 53%

Singapore News News

Singapore Singapore Latest News,Singapore Singapore Headlines

I am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.

Justice Brett Kavanaugh Is Not An ‘Honest Person’ And ‘Must Know’ He Assaulted Christine Blasey Ford, She Reportedly Says In MemoirThe stellar success of blockbuster drugs like Ozempic, Wegovy, Mounjaro and Zepbound has companies eager to break into the lucrative weight loss drug market — here are the hopeful rivals preparing to challenge Eli Lilly and Novo Nordisk for dominance in the obesity drug gold rush.

There is no guarantee promising results on efficacy, safety and tolerability from earlier trials will be replicated in larger late-stage trials. Even companies with candidates already in the later stages of testing are still going to require several years to gather and process the data and, should things pan out, time to work with regulators to secure approval.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in SG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Singapore Singapore Latest News, Singapore Singapore Headlines